Short answer
ACTUATE THERAPEUTICS, INC. (ACTU) filed its Q1 2026 10-Q quarterly report on May 14, 2026 for the quarter ended Mar 31, 2026.
Q1 2026 key financials · XBRL
- Net income
- −$6M
- +10.9% YoY
- EPS (diluted)
- −$0.24
- +25.0% YoY
Source: XBRL data from the ACTUATE THERAPEUTICS, INC. (ACTU) Q1 2026 10-Q on SEC EDGAR. USD.
ACTUATE THERAPEUTICS, INC. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- Risk-factor disclosures limited to introductory language
- No new, changed, regulatory, operational, competitive, market, or financial risks provided
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ACTUATE THERAPEUTICS, INC. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.